COORDINATION BETWEEN THE PARTIES. The Parties acknowledge that FivePrime may seek one (1) or more Third Party collaboration partner(s) for the Development and/or Commercialization of the Product in the Retained Territory (such partner, the “Retained Territory Partner”). After FivePrime grants any such Retained Territory Partner a license to Develop and/or Commercialize the Product in the Retained Territory, FivePrime will notify HGS in writing. Upon either FivePrime’s or HGS’ request, FivePrime, HGS and such Retained Territory Partner(s) shall discuss in good faith to coordinate the Development activities for the Product in the Licensed Territory and the Retained Territory.
Appears in 3 contracts
Sources: License and Collaboration Agreement (Five Prime Therapeutics Inc), License and Collaboration Agreement (Five Prime Therapeutics Inc), License and Collaboration Agreement (Five Prime Therapeutics Inc)